These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36166088)

  • 1. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
    Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
    Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
    Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
    BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
    Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
    Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
    Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
    Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer.
    Lu CF; Liao CY; Chao HS; Chiu HY; Wang TW; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
    Cancer Imaging; 2023 Jan; 23(1):9. PubMed ID: 36670497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
    Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
    Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
    Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
    Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients.
    Zhang G; Man Q; Shang L; Zhang J; Cao Y; Li S; Qian R; Ren J; Pu H; Zhou J; Zhang Z; Kong W
    Acad Radiol; 2024 Jun; 31(6):2591-2600. PubMed ID: 38290884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed Tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma.
    Shang Y; Chen W; Li G; Huang Y; Wang Y; Kui X; Li M; Zheng H; Zhao W; Liu J
    Radiol Med; 2023 Dec; 128(12):1483-1496. PubMed ID: 37749461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of multi-center
    Zuo Y; Liu L; Chang C; Yan H; Wang L; Sun D; Ruan M; Lei B; Xia X; Xie W; Song S; Huang G
    Med Phys; 2024 Jul; 51(7):4872-4887. PubMed ID: 38285641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
    Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
    Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
    Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
    Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
    Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
    Front Oncol; 2022; 12():904983. PubMed ID: 35875167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
    Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
    Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
    Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral and peritumoral CT radiomics in predicting prognosis in patients with chondrosarcoma: a multicenter study.
    Li Q; Wang N; Wang Y; Li X; Su Q; Zhang J; Zhao X; Dai Z; Wang Y; Sun L; Xing X; Yang G; Gao C; Nie P
    Insights Imaging; 2024 Jan; 15(1):9. PubMed ID: 38228977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.